Total Ideas
1
Bullish Ideas
0 (0%)
Bearish Ideas
Recent Activity
0
"LFMD: Telehealth co growing 20% revenue despite semaglutide headwinds from choosing $500 Wegovy vs $150 generics. Medicare approval for 21M Americans drove app downloads 400→900/day but revenue flat Q/Q. Management guides flat through 2025 but expects all weightloss customers covered by insurance/cheaper options by year-end. At 1.2x P/S vs prior 5x, return to growth could drive $40 price target by 2027."
Sentiment